Increasingly, payers and physicians are seeking real-world data on newly approved medications. Post-Authorisation Safety Studies (PASS) can provide this vital safety information and encourage market acceptance and uptake.
international clinical trials
Feasibility assessments allow sponsors to identify and potentially clear hurdles before a study launches. Bruce Smith, PharmD, Executive Director, Scientific and Operational Strategy, outlines strategies for feasibility studies in the spring edition of International Clinical Trials.